Skip to content
OpenCapital
Get started

Zimmer Biomet Holdings ZBH Hips — Revenue

Other product segments

Knees
$828.6M+4.5%
SET
$562.2M+19.5%
Technology And Data Bone Cement And Surgical
$171.8M+14.6%

Similar metrics at other companies

Stryker logo
SYKHips — Net Sales
$460M+3.8%
Ollie's Bargain Outlet Holdings, Inc. logo
OLLIHome — Revenue
$187.49M+8.6%
Johnson & Johnson logo
JNJHIPS — Sales to customers (Note 9)
$441M+4.8%
Xtant Medical Holdings logo
XTNTProduct — Revenue
$20.88M-28.7%
Orthofix Medical Inc. logo
OFIXGlobal Limb Reconstruction — Revenue
$32.86M+10.2%
Addus HomeCare logo
ADUSHome Health — Revenue
$16.73M-7.0%

Other financials

Income statement

See full
Revenue$2.1B+9.3%
Gross profit$1.5B+11.1%
Operating income$373.2M+27.7%
Net income$238.1M+30.8%
EPS (diluted)$1.22+34.1%

Balance sheet

See full
Cash & equivalents$424.2M-69.4%
Total debt$7.5B+4.1%
Total equity$12.7B+2.2%
Total assets$22.7B+2.4%

Cash flow

See full
Operating cash flow$359.4M-6.1%
CapEx$36.3M-18.6%
Free cash flow$323.1M-4.5%

Valuation

See full
Market cap$17.67B-6.9%
Enterprise value$24.72B-4.9%
P/E23.2×+0.2×
P/S2.1×-0.3×

Profitability

See full
Gross margin70%-1.0pp
Operating margin14%-3.0pp
Net margin9.1%-2.8pp
FCF margin17.3%-1.6pp

Returns & leverage

See full
Return on equity6.1%-1.2pp
Debt / equity0.6×0.0×
Current ratio1.7×-0.7×

Where this comes from

Reported directly by Zimmer Biomet Holdings in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Zimmer Biomet Holdings’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zimmer Biomet Holdings's hips — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zimmer Biomet Holdings's hips — revenue?
Zimmer Biomet Holdings (ZBH) reported hips — revenue of $524.1M in Q1 2026.
How has Zimmer Biomet Holdings's hips — revenue changed year-over-year?
Zimmer Biomet Holdings's hips — revenue increased by 5.7% year-over-year, from $495.8M to $524.1M.
What is the long-term trend for Zimmer Biomet Holdings's hips — revenue?
Over 4 years (2021 to 2025), Zimmer Biomet Holdings's hips — revenue has grown at a 3.1% compound annual growth rate (CAGR), from $1.86B to $2.09B.
What does hips — revenue mean?
This metric represents the total net sales generated from the Hips product category, which includes orthopedic reconstructive implants and related surgical components. It reflects the core revenue stream from hip replacement procedures, excluding any applicable sales taxes or similar assessments. This figure serves as a primary indicator of market demand and competitive positioning within the reconstructive joint replacement segment.